IPI Volume 3, Issue 2 - RGCC: A Leading Company in Analysis of CSCs as Progenitors of All Cancer Relapses

  • Published:1. Jun 2011
  • Dashboard:IPI Volume 3 Issue 2 RGCC A Leading Company in Analysis of CSC as Progenitors of All Cancer Relapses
  • Authors:

Read article

Find out more about the scientific basis of RGCC tests

More informations